Skip to main content
Premium Trial:

Request an Annual Quote

ArcherDx Immunoverse

ArcherDx has launched Archer Immunoverse, a suite of immune repertoire sequencing assays. The targeted panels analyze RNA using Archer's patented Anchored Multiplex PCR (AMP) chemistry for open-ended amplification from molecular barcoded adaptors and next-generation sequencing to characterize the immune repertoire. After sequencing, the Immune Repertoire pipeline is used to identify clonotypes. The workflow requires less than 3.5 hours of hands-on time and between 25 nanograms and 2 micrograms of input RNA from peripheral blood mononuclear cells, formalin-fixed paraffin-embedded tissue, or fresh frozen tissue.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more